Arazasetron

DB19237InvestigationalSmall molecule

Arazasetron is currently under investigation in clinical trial NCT05258773 (Evaluation of the Presence of SENS-401 in the Perilymph).

Chemical structure of Arazasetron
Mechanism
Curator reviewed
Formula / weight
C17H20ClN3O3 · 349.82 g/mol (avg)
Also known as
Azasetron, r · R-Azasetron
Code names
SENS-401

Resolves to

Compound
UNII61JC7L0Q4OCAS2025360-90-9
Structure
InChIKeyWUKZPHOXUVCQOR-ZDUSSCGKSA-NSMILESCN1C(=O)COC2=C1C=C(Cl)C=C2C(=O)N[C@H]1CN2CCC1CC2

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which companies are running trials of Arazasetron, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In